Schalken JA - Search Results

1

A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH.

Wicker N, Carles A, Mills IG, Wolf M, Veerakumarasivam A, Edgren H, Boileau F, Wasylyk B, Schalken JA, Neal DE, Kallioniemi O, Poch O. Wicker N, et al. Among authors: schalken ja. BMC Genomics. 2007 Mar 29;8:84. doi: 10.1186/1471-2164-8-84. BMC Genomics. 2007. PMID: 17394638 Free PMC article.

2

Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis.

Brants J, Semenchenko K, Wasylyk C, Robert A, Carles A, Zambrano A, Pradeau-Aubreton K, Birck C, Schalken JA, Poch O, de Mey J, Wasylyk B. Brants J, et al. Among authors: schalken ja. PLoS One. 2012;7(12):e51258. doi: 10.1371/journal.pone.0051258. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251473 Free PMC article.

3

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.

Iljin K, Wolf M, Edgren H, Gupta S, Kilpinen S, Skotheim RI, Peltola M, Smit F, Verhaegh G, Schalken J, Nees M, Kallioniemi O. Iljin K, et al. Cancer Res. 2006 Nov 1;66(21):10242-6. doi: 10.1158/0008-5472.CAN-06-1986. Cancer Res. 2006. PMID: 17079440 Free article.

4

Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.

Wasylyk C, Zambrano A, Zhao C, Brants J, Abecassis J, Schalken JA, Rogatsch H, Schaefer G, Pycha A, Klocker H, Wasylyk B. Wasylyk C, et al. Among authors: schalken ja. Int J Cancer. 2010 Dec 1;127(11):2542-53. doi: 10.1002/ijc.25261. Int J Cancer. 2010. PMID: 20162578 Free article.

5

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.

Vainio P, Wolf M, Edgren H, He T, Kohonen P, Mpindi JP, Smit F, Verhaegh G, Schalken J, Perälä M, Iljin K, Kallioniemi O. Vainio P, et al. Prostate. 2012 May 15;72(7):789-802. doi: 10.1002/pros.21487. Epub 2011 Sep 14. Prostate. 2012. PMID: 21919029

6

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.

Semenchenko K, Wasylyk C, Cheung H, Tourrette Y, Maas P, Schalken JA, van der Pluijm G, Wasylyk B. Semenchenko K, et al. Among authors: schalken ja. PLoS One. 2016 Jul 18;11(7):e0159531. doi: 10.1371/journal.pone.0159531. eCollection 2016. PLoS One. 2016. PMID: 27427904 Free PMC article.

7

The transcription factor Net regulates the angiogenic switch.

Zheng H, Wasylyk C, Ayadi A, Abecassis J, Schalken JA, Rogatsch H, Wernert N, Maira SM, Multon MC, Wasylyk B. Zheng H, et al. Among authors: schalken ja. Genes Dev. 2003 Sep 15;17(18):2283-97. doi: 10.1101/gad.272503. Genes Dev. 2003. PMID: 12975317 Free PMC article.

8

A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.

Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B. Zhao F, et al. Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z. Clin Epigenetics. 2018. PMID: 30470249 Free PMC article.

9

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi JP, Kohonen P, Fey V, Perälä M, Smit F, Verhaegh G, Schalken J, Alanen KA, Kallioniemi O, Iljin K. Vainio P, et al. Am J Pathol. 2011 Feb;178(2):525-36. doi: 10.1016/j.ajpath.2010.10.002. Am J Pathol. 2011. PMID: 21281786 Free PMC article.

10

hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, Klocker H, Wasylyk B, Voller M, Aalders T, Schalken JA, Oren M, Rotter V. Kogan I, et al. Among authors: schalken ja. Cancer Res. 2006 Apr 1;66(7):3531-40. doi: 10.1158/0008-5472.CAN-05-2183. Cancer Res. 2006. PMID: 16585177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

420 results

Search Page